Three days before President Donald Trump was sworn into office, the Department of Health and Human Services announced the award of $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines.
WHY THIS MATTERS
HHS provides $590 million to Moderna amid vaccine controversy
